EHDEN colleagues were very active at one of the key Health Economics and Outcomes Research (HEOR)conferences in Europe, The Professional Society for Health Economics and Outcomes Research (ISPOR) European meeting, held in Vienna, 6-9th November 2022, the first in-person in Europe since 2019. Within the domain of Health Technology Assessment (HTA), our colleagues in work … Read more
On Monday 31st October, NICE hosted a virtual workshop entitled ‘Regulators are formally adopting real world evidence, when will health technology assessment?’. It was organised as part of our work within the Innovative Medicines Initiative grant-funded project European Health Data & Evidence Network (EHDEN), in collaboration with GetReal Institute. The half-day workshop, moderated by Dr … Read more
COVID-19 was declared a pandemic by the WHO in March of 2020 and EHDEN was formally launched in November 2018. With a solid foundation of Data Partners in place by early 2020, and since then, EHDEN has been collaborating with OHDSI (Observational Health Data Science and Informatics), our growing base of Data Partners, and other … Read more
See also the accompanying article in Uppsala Reports here. The week of 5 September had more than thirty colleagues from the Uppsala Monitoring Centre (UMC), EHDEN, DARWIN EU, and EHDEN Data Partners come together in Uppsala, Sweden to take part in the UMC/EHDEN pharmacovigilance evidence-a-thon. The specific objective of this IMI EHDEN-sponsored event was to … Read more
Brussels, Belgium, 5th September 2022: We are delighted to announce and celebrate the special award from the International Society of Pharmacoepidemiology (ISPE) for recognisable and impactful contributions to public health during the COVID-19 pandemic awarded to Prof Dani Prieto-Alhambra, EHDEN’s Research Coordinator, Professor of Pharmaco and Device Epidemiology, NDORMS, University of Oxford, and Professor, Real … Read more
My team and I are very pleased to see the COVID-19 virus waning thanks to vaccines (and mutations), and that we’re now in a much better place. However, it’s nevertheless still with us and there’s necessarily great interest in the long-term consequences of long COVID, i.e., infection/re-infection, infection with different variants, infection with people vaccinated, … Read more
The EHDEN project Consortium, like everyone, is looking forward to a recuperative and hopefully safe break over the festive season in Europe, and wishes the same for all our colleagues and partners, too. It has been a hard year, against a backdrop of a continuing COVID-19 pandemic and now the rise of the Omicron SARS-COV-2 … Read more
A recent survey in England indicated that, during the COVID-19 pandemic, the public had learned more about how real world data (RWD) can be used both for monitoring public health and for research. Words such as epidemiology and vaccine effectiveness now trip off the tongue and are no longer the preserve of scientists. From society’s … Read more
With the growing use of regulatory tools such as conditional approvals and breakthrough designations, the traditional bottleneck of regulatory approval is today seen as far less problematic than it was previously. However, the early assessment of new products is also increasingly accompanied by smaller datasets that are often extrapolated for outcomes and survival. This creates … Read more
The Observational Health Data Sciences and Informatics (OHDSI) international community will host a COVID-19 virtual study-a-thon this week (March 26-29) to inform healthcare decision-making in response to the current global pandemic. More than 290 people from 29 different countries have registered for the four-day online event, which will be led by researchers from Oxford University, … Read more